2026

Regulatory Approvals

FDA clears first drug for MCT8 deficiency

Sep 29, 2026

FDA clears first drug for MCT8 deficiency pharmaphorum.com

Regulatory Approvals

FDA Approves Teva’s DEGEVMA Biosimilar to Xgeva for Cancer Bone Complications

Sep 29, 2026

FDA Approves Teva’s DEGEVMA Biosimilar to Xgeva for Cancer Bone Complications clinicaltrialvanguard.com

Credit Ratings

Fitch revises Oyo parent’s outlook to positive, sees potential deleveraging – business

Sep 29, 2026

Fitch revises Oyo parent's outlook to positive, sees potential deleveraging business-standard.com

Credit Ratings

S&P affirms Malaysia’s sovereign ratings, maintains stable outlook

Sep 29, 2026

S&P affirms Malaysia’s sovereign ratings, maintains stable outlook The Star

Credit Ratings

Tata Sons IPO unlikely to affect group ratings immediately, but could change support outlook: S&P Global

Sep 29, 2026

Tata Sons IPO unlikely to affect group ratings immediately, but could change support outlook: S&P Global TradingView

Business Economy Finance

Commodities Price Update: Crude Oil $104.12, Brent $113.43, Copper $6.48, Coal $104.75 — Oct 31, 2026 4:00 PM EDT

Business Economy Finance

Commodities Price Update: Crude Oil $104.12, Brent $113.43, Copper $6.48, Coal $104.75 — Oct 31, 2026 11:00 AM EDT

Regulation

Appeals court reverses rejection of damages award against NFL in Sunday Ticket class action

Regulation

SEC Issues Exemptive Relief from Treasury Clearing Requirements for Certain Inter-Affiliate and Non-U.S. Repo Transactions